Search Results - "DE PUNDER, Yvonne M. R"

The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry by DE PUNDER, Yvonne M. R, FRANSEN, Jaap, KIEVIT, Wietske, HOUTMAN, Pieternella M, VISSER, Henk, VAN DE LAAR, Mart A. F. J, VAN RIEL, Piet L. C. M

“…To evaluate the prevalence of clinical remission and minimal disease activity according to the ACR/European League Against Rheumatism (EULAR) remission, DAS-28…”
Get full text

Should We Redefine Treatment Targets in Rheumatoid Arthritis? Low Disease Activity Is Sufficiently Strict for Patients Who Are Anticitrullinated Protein Antibody-negative by DE PUNDER, Yvonne M. R, HENDRIKX, Jos, DEN BROEDER, Alfons A, PASCUAL, Elia Valls, VAN RIEL, Piet L, FRANSEN, Jaap

“…Clinical remission currently is the treatment target for all patients with rheumatoid arthritis (RA). At the same level of inflammation, the prognosis…”
Get full text

A simplified baseline prediction model for joint damage progression in rheumatoid arthritis: a step toward personalized medicine by de Punder, Yvonne M R, van Riel, Piet L C M, Fransen, Jaap

“…To compare the performance of an extended model and a simplified prognostic model for joint damage in rheumatoid arthritis (RA) based on 3 baseline risk…”
Get full text

Personalizing treatment targets in rheumatoid arthritis by using a simple prediction model by de Punder, Yvonne M R, Jansen, Tim L Th A, van Ede, Annelies E, den Broeder, Alfons A, van Riel, Piet L C M, Fransen, Jaap

“…To develop a personalized treatment target approach in patients with rheumatoid arthritis (RA) based on baseline risk factors for joint damage progression in…”
Get full text

Rheumatoid arthritis: understanding joint damage and physical disability in RA by de Punder, Yvonne M R, van Riel, Piet L C M

Get full text

Understanding joint damage and physical disability in RA by de Punder, Yvonne M. R., van Riel, Piet L. C. M.

“…Although, overall, joint damage correlates with physical disability in rheumatoid arthritis, damage to cartilage and to bone might contribute unequally. New…”
Get full text